CD4 and neoplasm: Furthermore, flow cytometry analysis revealed that RocA significantly increased the tumor-infiltrating lymphocytes (TILs) (Fig. 1D and 1E), including both CD4+ and CD8+ T cells (Fig. 1D and 1F).